Search Browse Earnings

Poseida Therapeutics, Inc. — SlamSEC

Poseida Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$130.5M

+317.7% YoY

FY 2023

Adj. EBITDA

-$54.8M

-42.0% margin

FY 2023

Net Income

-$64.0M

-49.0% margin

FY 2023

EPS (Diluted)

-$0.89

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$81.4M

FY 2023

Total Debt

$58.3M

FY 2023

Net Cash

$23.1M

FY 2023

Enterprise Value

—

Debt / EBITDA

0.4x

FY 2023

EV / EBITDA

—

Employees

—